Walter G Park, MD
Gastroenterology · Stanford
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 18
- 4 carriers
- Offices
- 3
Offices
3 locations · Stanford Health Care · 3,152 clinicians in this group
Hospitals listed: Stanford Health Care. That is not proof they admit you there this week.
Plans that list them
18 plans · 4 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Park’s office at (650) 723-4000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
18 of 18 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A88008 · Current
Licensed to practise in California · since 2004 · expires 2028-07-31 · Johns Hopkins University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$69,306
Medicare paid this office $69,306 for 359 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Ultrasound exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope through mouth | 105 | $17,047 | $158 |
| Ultrasound guided needle aspiration or biopsy of esophagus using a flexible endoscope | 78 | $15,177 | $192 |
| Return visit (30+ min) | 69 | $8,406 | $109 |
| Long return visit (40+ min) | 42 | $5,958 | $142 |
| New patient visit (45+ min) | 39 | $5,647 | $145 |
See all 12 services
| Ultrasound exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope through mouth | 105 | $17,047 | $158 |
| Ultrasound guided needle aspiration or biopsy of esophagus using a flexible endoscope | 78 | $15,177 | $192 |
| Return visit (30+ min) | 69 | $8,406 | $109 |
| Long return visit (40+ min) | 42 | $5,958 | $142 |
| New patient visit (45+ min) | 39 | $5,647 | $145 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 11 | $2,587 | $235 |
| Biopsy of large bowel using a flexible endoscope | 19 | $1,932 | $102 |
| New patient visit (45+ min) | 16 | $1,673 | $105 |
| Return visit (30+ min) | 19 | $1,671 | $80 |
| Long return visit (40+ min) | 14 | $1,566 | $112 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 59 | $1,561 | $26 |
| New patient visit (30+ min) | 13 | $1,256 | $97 |
Procedures Medicare counted
| Colonoscopy | 44 | More than 61% of doctors who do this |
| Upper gastrointestinal (GI) endoscopy for acid reflux | 271 | More than 94% of doctors who do this |
Who their Medicare patients are
359 Original Medicare patients in 2024. Average age 73 · Under 65 9% · 85 and older 6% · Women 59% · Also on Medicaid 18% · Health risk score 1.33. At or below the middle of the specialty; the typical gastroenterology clinician is at 1.42.
Conditions among them: High blood pressure 68% · Diabetes 31% · Cancer 27% · Coronary heart disease 25% · Chronic kidney disease 22% · Atrial fibrillation 19% · Depression 19% · Heart failure 12% · COPD 11% · Stroke 8%.
The office billed $601,329, Medicare allowed $91,436 and paid $69,306; for 540 services of 24 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 359 | 540 | 73 | 1.33 | $601,329 | $69,306 |
| 2023 | 333 | 494 | 72 | 1.67 | $488,993 | $63,339 |
| 2022 | 373 | 570 | 72 | 1.78 | $556,669 | $69,989 |
| 2021 | 337 | 512 | 72 | 1.74 | $555,672 | $66,702 |
| 2020 | 272 | 484 | 71 | 1.69 | $487,317 | $54,055 |
| 2019 | 338 | 595 | 72 | 1.72 | $548,075 | $71,107 |
| 2018 | 276 | 489 | 70 | 1.71 | $367,243 | $56,790 |
| 2017 | 305 | 583 | 69 | 1.90 | $460,958 | $64,808 |
| 2016 | 250 | 356 | 70 | 1.68 | $283,524 | $45,697 |
| 2015 | 276 | 458 | 70 | 2.08 | $400,654 | $59,573 |
| 2014 | 252 | 442 | 70 | 1.97 | $426,464 | $54,707 |
| 2013 | 260 | 496 | 68 | 1.59 | $433,319 | $62,802 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 12 services
| Ultrasound guided needle aspiration or biopsy of esophagus using a flexible endoscope | 80 | $17,047 | $205 |
| Ultrasound exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope through mouth | 70 | $10,681 | $153 |
| New patient visit (45+ min) | 43 | $5,012 | $117 |
| New patient visit (45+ min) | 34 | $3,679 | $108 |
| Long return visit (40+ min) | 26 | $3,107 | $119 |
| Long return visit (40+ min) | 26 | $2,953 | $114 |
| Return visit (30+ min) | 27 | $2,864 | $90 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 12 | $2,711 | $226 |
| Return visit (30+ min) | 27 | $2,355 | $84 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 41 | $1,794 | $44 |
| Biopsy of large bowel using a flexible endoscope | 12 | $1,496 | $125 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 11 | $1,196 | $109 |
2022: 15 services
| Ultrasound guided needle aspiration or biopsy of esophagus using a flexible endoscope | 66 | $13,803 | $200 |
| Ultrasound exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope through mouth | 63 | $10,711 | $167 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 38 | $4,599 | $121 |
| New patient visit (45+ min) | 35 | $4,203 | $120 |
| Long return visit (40+ min) | 34 | $4,179 | $123 |
| Long return visit (40+ min) | 30 | $3,504 | $113 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 13 | $3,039 | $234 |
| New patient visit (45+ min) | 27 | $3,037 | $112 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 48 | $2,508 | $52 |
| Return visit (30+ min) | 30 | $2,435 | $76 |
| Return visit (30+ min) | 23 | $2,080 | $90 |
| Biopsy of large bowel using a flexible endoscope | 18 | $1,996 | $111 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 11 | $1,519 | $89 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 13 | $1,486 | $106 |
| New patient visit (30+ min) | 11 | $816 | $74 |
2021: 11 services
| Ultrasound guided needle aspiration or biopsy of esophagus using a flexible endoscope | 71 | $15,046 | $212 |
| Ultrasound exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope through mouth | 61 | $10,810 | $177 |
| New patient visit (45+ min) | 33 | $3,816 | $116 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 16 | $3,758 | $235 |
| Biopsy of large bowel using a flexible endoscope | 26 | $3,690 | $142 |
| Return visit (30+ min) | 35 | $3,197 | $89 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 60 | $3,027 | $49 |
| New patient visit (45+ min) | 24 | $2,812 | $117 |
| Long return visit (40+ min) | 17 | $2,704 | $142 |
| Return visit (30+ min) | 24 | $2,119 | $88 |
| Long return visit (40+ min) | 14 | $1,712 | $122 |
2020: 11 services
| Ultrasound guided needle aspiration or biopsy of esophagus using a flexible endoscope | 57 | $12,701 | $215 |
| Ultrasound exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope through mouth | 53 | $9,374 | $177 |
| Biopsy of large bowel using a flexible endoscope | 19 | $2,490 | $131 |
| Return visit (30+ min) | 30 | $2,490 | $73 |
| Long return visit (40+ min) | 22 | $2,091 | $91 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 11 | $2,042 | $186 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 75 | $1,988 | $27 |
| New patient visit (45+ min) | 21 | $1,957 | $93 |
| Return visit (30+ min) | 28 | $1,930 | $69 |
| Long return visit (40+ min) | 16 | $1,679 | $99 |
| New patient visit (45+ min) | 12 | $1,428 | $119 |
2019: 17 services
| Ultrasound guided needle aspiration or biopsy of esophagus using a flexible endoscope | 88 | $19,371 | $215 |
| Ultrasound exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope through mouth | 67 | $11,381 | $170 |
| Long return visit (40+ min) | 38 | $3,797 | $95 |
| Injection of diagnostic or therapeutic substance or marker in esophagus, stomach, and/or upper small bowel using a flexible endoscope | 12 | $2,947 | $246 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 13 | $2,735 | $210 |
| Long return visit (40+ min) | 29 | $2,675 | $86 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 70 | $2,473 | $35 |
| Biopsy of large bowel using a flexible endoscope | 19 | $2,308 | $121 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 18 | $2,228 | $124 |
| New patient visit (60+ min) | 15 | $1,924 | $128 |
| New patient visit (45+ min) | 18 | $1,796 | $100 |
| Return visit (30+ min) | 24 | $1,624 | $62 |
| Return visit (30+ min) | 20 | $1,558 | $68 |
| New patient visit (60+ min) | 12 | $1,533 | $128 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 13 | $1,380 | $106 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 12 | $990 | $66 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 25 | $117 | $5 |
2018: 11 services
| Ultrasound guided needle aspiration or biopsy of esophagus using a flexible endoscope | 57 | $11,434 | $201 |
| Ultrasound exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope through mouth | 64 | $10,604 | $166 |
| Long return visit (40+ min) | 46 | $4,316 | $88 |
| New patient visit (45+ min) | 45 | $4,258 | $95 |
| Biopsy of large bowel using a flexible endoscope | 19 | $2,999 | $158 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 13 | $2,715 | $94 |
| Return visit (30+ min) | 33 | $2,495 | $61 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 32 | $2,056 | $64 |
| Long return visit (40+ min) | 15 | $1,580 | $99 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 12 | $1,467 | $122 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 19 | $101 | $5 |
2017: 13 services
| Ultrasound guided needle aspiration or biopsy of esophagus using a flexible endoscope | 59 | $12,403 | $210 |
| Ultrasound exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope through mouth | 45 | $7,675 | $171 |
| New patient visit (45+ min) | 52 | $5,589 | $107 |
| Long return visit (40+ min) | 44 | $4,569 | $93 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 25 | $4,211 | $65 |
| Biopsy of large bowel using a flexible endoscope | 24 | $3,913 | $163 |
| Return visit (30+ min) | 45 | $3,705 | $64 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 29 | $3,661 | $122 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 28 | $2,654 | $95 |
| Diagnostic exam of large bowel using a flexible endoscope | 12 | $1,954 | $163 |
| New patient visit (30+ min) | 11 | $747 | $68 |
| Short return visit (20+ min) | 12 | $730 | $46 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 37 | $178 | $5 |
2016: 9 services
| Ultrasound guided needle aspiration or biopsy of esophagus using a flexible endoscope | 59 | $13,218 | $217 |
| Ultrasound exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope through mouth | 35 | $5,913 | $169 |
| New patient visit (45+ min) | 43 | $4,614 | $107 |
| Long return visit (40+ min) | 35 | $3,369 | $89 |
| Return visit (30+ min) | 37 | $2,662 | $67 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 17 | $1,960 | $115 |
| Biopsy of large bowel using a flexible endoscope | 12 | $1,655 | $138 |
| New patient visit (30+ min) | 19 | $1,288 | $68 |
| Short return visit (20+ min) | 20 | $911 | $43 |
2015: 13 services
| Ultrasound guided needle aspiration or biopsy of esophagus using a flexible endoscope | 48 | $11,353 | $223 |
| Long return visit (40+ min) | 54 | $5,544 | $89 |
| Ultrasound exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope through mouth | 28 | $5,141 | $184 |
| New patient visit (45+ min) | 43 | $4,571 | $106 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 28 | $3,547 | $122 |
| New patient visit (60+ min) | 22 | $2,952 | $134 |
| Biopsy of large bowel using a flexible endoscope | 16 | $2,571 | $151 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 21 | $2,394 | $109 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 21 | $2,272 | $65 |
| Diagnostic exam of large bowel using a flexible endoscope | 12 | $2,201 | $183 |
| Return visit (30+ min) | 26 | $1,881 | $70 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 17 | $1,682 | $99 |
| Short return visit (20+ min) | 15 | $774 | $46 |
2014: 16 services
| Ultrasound guided needle aspiration or biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 23 | $5,500 | $239 |
| New patient visit (45+ min) | 45 | $5,087 | $113 |
| Ultrasound exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 23 | $4,882 | $212 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 14 | $3,828 | $273 |
| New patient visit (60+ min) | 26 | $3,798 | $146 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 44 | $3,510 | $76 |
| Biopsy of large bowel using a flexible endoscope | 18 | $3,379 | $188 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 18 | $3,144 | $175 |
| Long return visit (40+ min) | 30 | $2,887 | $96 |
| Return visit (30+ min) | 34 | $2,657 | $65 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 18 | $2,311 | $92 |
| Diagnostic exam of large bowel using a flexible endoscope | 11 | $2,120 | $193 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 15 | $1,826 | $122 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 13 | $1,427 | $95 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 17 | $1,409 | $64 |
| New patient visit (30+ min) | 13 | $697 | $54 |
2013: 15 services
| Ultrasound guided needle aspiration or biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 21 | $7,782 | $371 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 34 | $6,109 | $175 |
| Biopsy of large bowel using a flexible endoscope | 29 | $5,520 | $190 |
| Ultrasound exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 21 | $5,384 | $256 |
| Return visit (30+ min) | 63 | $4,715 | $65 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 46 | $4,276 | $93 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 15 | $4,138 | $276 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 23 | $4,024 | $89 |
| New patient visit (45+ min) | 34 | $3,457 | $102 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 20 | $1,862 | $62 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 15 | $1,775 | $118 |
| Long return visit (40+ min) | 14 | $1,339 | $89 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 12 | $1,241 | $103 |
| New patient visit (30+ min) | 17 | $994 | $58 |
| Short return visit (20+ min) | 18 | $880 | $42 |
Drugs they prescribed that Part D paid
$307,441
Pharmacies billed $307,441 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
181 generic and 92 brand-name prescriptions · $307,441 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Creon | 55 | $257,661 | $4,685 |
| Pertzye | 11 | $16,647 | $1,513 |
| Omeprazole | 69 | $729 | $11 |
| Peg 3350-Electrolyte | 32 | $553 | $17 |
| Gabapentin | 12 | $369 | $31 |
See all 6 drugs
| Creon | 55 | $257,661 | $4,685 |
| Pertzye | 11 | $16,647 | $1,513 |
| Omeprazole | 69 | $729 | $11 |
| Peg 3350-Electrolyte | 32 | $553 | $17 |
| Gabapentin | 12 | $369 | $31 |
| Dicyclomine | 12 | $319 | $27 |
Year by year
| 2024 | 273 | 115 | None | 34% | $307,441 |
| 2023 | 293 | 101 | None | 46% | $362,705 |
| 2022 | 339 | 121 | None | 48% | $477,201 |
| 2021 | 294 | 135 | None | 52% | $381,029 |
| 2020 | 321 | 110 | None | 38% | $320,447 |
| 2019 | 345 | 122 | None | 34% | $206,067 |
| 2018 | 224 | 89 | None | 45% | $168,939 |
| 2017 | 157 | 65 | None | 44% | $93,901 |
| 2016 | 102 | 64 | None | None | $20,492 |
| 2015 | 172 | 81 | None | 24% | $24,968 |
| 2014 | 161 | 73 | None | 29% | $31,438 |
| 2013 | 137 | 84 | None | 33% | $21,287 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 3 drugs
| Creon | 98 | $298,424 | $3,045 |
| Omeprazole | 79 | $1,960 | $25 |
| Peg 3350-Electrolyte | 27 | $563 | $21 |
2022: 8 drugs
| Creon | 113 | $386,104 | $3,417 |
| Zenpep | 11 | $57,772 | $5,252 |
| Omeprazole | 59 | $698 | $12 |
| Peg 3350-Electrolyte | 34 | $592 | $17 |
| Pregabalin | 11 | $539 | $49 |
| Gabapentin | 13 | $214 | $16 |
| Pantoprazole | 12 | $197 | $16 |
| Prednisone | 11 | $161 | $15 |
2021: 6 drugs
| Creon | 78 | $277,307 | $3,555 |
| Zenpep | 16 | $80,416 | $5,026 |
| Omeprazole | 45 | $752 | $17 |
| Peg 3350-Electrolyte | 45 | $722 | $16 |
| Pantoprazole | 11 | $170 | $15 |
| Ciprofloxacin | 18 | $67 | $4 |
2020: 8 drugs
| Creon | 76 | $225,493 | $2,967 |
| Zenpep | 22 | $81,816 | $3,719 |
| Omeprazole | 53 | $750 | $14 |
| Gabapentin | 21 | $288 | $14 |
| Pantoprazole | 19 | $191 | $10 |
| Gavilyte-G | 14 | $177 | $13 |
| Ondansetron Odt | 14 | $134 | $10 |
| Ciprofloxacin | 23 | $86 | $4 |
2019: 8 drugs
| Creon | 79 | $171,369 | $2,169 |
| Omeprazole | 59 | $614 | $10 |
| Gavilyte-N | 15 | $289 | $19 |
| Peg 3350-Electrolyte | 14 | $284 | $20 |
| Pantoprazole | 11 | $252 | $23 |
| Ondansetron Odt | 18 | $176 | $10 |
| Ciprofloxacin | 25 | $91 | $4 |
| Ranitidine | 12 | $81 | $7 |
2018: 5 drugs
| Creon | 61 | $146,428 | $2,400 |
| Omeprazole | 24 | $216 | $9 |
| Gavilyte-N | 14 | $212 | $15 |
| Gavilyte-G | 11 | $158 | $14 |
| Ciprofloxacin | 16 | $69 | $4 |
2017: 4 drugs
| Creon | 37 | $81,774 | $2,210 |
| Omeprazole | 15 | $202 | $13 |
| Peg 3350-Electrolyte | 12 | $179 | $15 |
| Ciprofloxacin | 12 | $31 | $3 |
2016: 2 drugs
| Omeprazole | 26 | $223 | $9 |
| Ciprofloxacin | 30 | $130 | $4 |
2015: 5 drugs
| Creon | 15 | $20,847 | $1,390 |
| Omeprazole | 40 | $424 | $11 |
| Peg 3350-Electrolyte | 12 | $201 | $17 |
| Pantoprazole | 24 | $168 | $7 |
| Ciprofloxacin | 20 | $84 | $4 |
2014: 5 drugs
| Creon | 15 | $17,111 | $1,141 |
| Pantoprazole | 20 | $1,236 | $62 |
| Peg-3350 | 15 | $260 | $17 |
| Omeprazole | 14 | $211 | $15 |
| Ciprofloxacin | 17 | $72 | $4 |
2013: 4 drugs
| Omeprazole | 31 | $1,470 | $47 |
| Peg-3350 With Flavor Packs | 23 | $449 | $20 |
| Gavilyte-N | 11 | $233 | $21 |
| Ciprofloxacin | 12 | $58 | $5 |
Money from drug and device companies
$86,880 in 2025
| 2025 | 10 | 23 | $85,608 | $86,880 |
| 2024 | 5 | 13 | $66,289 | $66,463 |
| 2023 | 5 | 14 | $11,363 | $12,238 |
| 2022 | 6 | 9 | $9,932 | $10,070 |
| 2021 | 6 | 13 | $20,618 | $20,679 |
| 2020 | 1 | 26 | $15,990 | $17,183 |
| 2019 | 5 | 15 | $500 | $2,946 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| CapsoVision | Capsocam Plus | $83,108 | 10 payments
|
| Olympus America | Single Use Aspiration Needle Na-U200h | $1,209 | 3 payments
|
| Amgen | Uplizna | $1,166 | 3 payments
|
| Aimmune Therapeutics | Zenpep | $700 | 1 payment
|
| Fujifilm Healthcare Americas | Fujifilm | $179 | 1 payment
|
| Celltrion | None | $150 | 1 payment
|
See all 23 published payments
| CapsoVision | Consulting · 2025-12-05 | Capsocam Plus | $2,713 |
| CapsoVision | Consulting · 2025-12-05 | Capsocam Colon | $11,293 |
| Aimmune Therapeutics | Consulting · 2025-12-04 | Zenpep | $700 |
| Olympus America | Travel · 2025-11-19 | Single Use Aspiration Needle Na-U200h | $474 |
| Olympus America | Travel · 2025-11-19 | Single Use Aspiration Needle Na-U200h | $35 |
| CapsoVision | Consulting · 2025-10-15 | Capsocam Colon | $6,783 |
| CapsoVision | Consulting · 2025-07-30 | Capsocam Plus | $9,358 |
| Fujifilm Healthcare Americas | Meals · 2025-07-09 | Fujifilm | $179 |
| CapsoVision | Consulting · 2025-07-03 | Capsocam Plus | $9,358 |
| CapsoVision | Consulting · 2025-06-25 | Capsocam Colon | $8,501 |
| Celltrion | Meals · 2025-05-31 | None | $150 |
| CapsoVision | Consulting · 2025-05-21 | Capsocam Plus | $12,856 |
| Olympus America | Consulting · 2025-05-15 | None | $700 |
| Amgen | Consulting · 2025-05-06 | Uplizna | $220 |
| Boston Scientific | Meals · 2025-05-04 | Exalt Model D | $150 |
| Amgen | Meals · 2025-05-04 | Uplizna | $66 |
| CapsoVision | Consulting · 2025-04-03 | Capsocam Plus | $8,888 |
| Erbe USA | Meals · 2025-03-29 | Vio3/Hybridknifeflex | $30 |
| CapsoVision | Consulting · 2025-03-06 | Capsocam Plus | $338 |
| Olympus Corporation of the Americas | Meals · 2025-02-12 | None | $100 |
| Abbvie | Meals · 2025-01-16 | Creon | $89 |
| CapsoVision | Consulting · 2025-01-08 | Capsocam Plus | $13,020 |
| Amgen | Consulting · 2025-01-07 | Uplizna | $880 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $66,463
| CapsoVision | Capsocam Colon | $60,585 | 5 payments
|
| Amgen | Uplizna | $2,989 | 4 payments
|
| Pfizer | None | $2,025 | 1 payment
|
| Olympus Medical Systems | None | $769 | 2 payments
|
| Abbvie | Creon | $95 | 1 payment
|
2023: $12,238
| CapsoVision | Capsocam Colon | $7,305 | 3 payments
|
| Olympus | None | $3,445 | 7 payments
|
| Olympus America | Evis Eus Endoscopic Ultrasound Center | $745 | 2 payments
|
| Pfizer | None | $675 | 1 payment
|
| Cook Medical | Echotip | $68 | 1 payment
|
2022: $10,070
| Nestle HealthCare Nutrition | Zenpep | $3,900 | 2 payments
|
| Horizon Therapeutics plc | Uplizna | $2,250 | 1 payment
|
| Bayer HealthCare Pharmaceuticals | None | $2,244 | 2 payments
|
| Olympus | None | $1,538 | 2 payments
|
| Olympus Corporation of the Americas | None | $79 | 1 payment
|
| Medtronic | Gi Genius | $59 | 1 payment
|
2021: $20,679
| Olympus America | Evis Exera II Ultrasound Gastrovideoscope | $7,380 | 6 payments
|
| Nestle HealthCare Nutrition | Zenpep | $5,500 | 1 payment
|
| AbbVie | Creon | $4,538 | 2 payments
|
| Akcea Therapeutics | None | $2,000 | 2 payments
|
| Samsung Bioepis Co. | None | $1,200 | 1 payment
|
| Olympus Corporation of the Americas | Single Use Aspiration Needle Na-U200h | $61 | 1 payment
|
2020: $17,183
| Olympus America | Olympus Biliary Devices | $17,183 | 26 payments
|
2019: $2,946
| AbbVie | Creon | $2,071 | 9 payments
|
| Eagle Pharmaceuticals | None | $500 | 1 payment
|
| Allergan | Zenpep | $191 | 2 payments
|
| Olympus America | Olympus Ultrasound Devices | $111 | 2 payments
|
| Covidien LP | Beacon | $72 | 1 payment
|
Research money
Money a company paid to run a study. Where it went to their institution, the clinician is named as an investigator and did not receive it; the amount covers the whole study, often across many sites.
| ABBVIE INC. · Heor Study · 2021 | Their institution | $24,351 |
| ABBVIE INC. · Creon · 2022 | Their institution | $18,517 |
| AbbVie Inc. · Creon · 2020 | This clinician | $15,125 |
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 76.5 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1538355672
- Licence
- CA A88008California A88008: Current · expires 2028-07-31
- Trained
- Johns Hopkins University School of Medicine, 2003
- Group
- Stanford Health Care
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207RG0100X (207RG0100X)
- Mailing address
- 300 Pasteur Dr, Stanford, CA, 94305
- NPI first listed
- 2007-09-21
- NPI last updated
- 2026-08-24
- NPI record certified
- 2026-08-24
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 300 Pasteur Dr # Mc5187, Stanford, CA, 94305